Cision PR Newswire

Brii Biosciences Provides Corporate Updates and Reports 2026 Interim Financial Results

Topline Data from Phase 2b Studies Inform HBV Functional Cure Strategy; Additional Data Expected in 2H 2026 Emerging Discovery Programs Build Momentum BRII-5395 mRNA Cancer Vaccine Moving into Clinical Evaluation for HCC Strong Cash Position Supports Continued Strategic Execution Conference Call Scheduled: August 21 at...

Ractigen Therapeutics Announces Completion of Enrollment and First Dosing in Phase II Clinical Trial of RAG-17 for SOD1-ALS

NANTONG, China, Aug. 6, 2026 /PRNewswire/ -- Ractigen Therapeutics, a clinical-stage biotechnology company pioneering next-generation RNA therapeutics, today announced the completion of patient enrollment and...

Daqo New Energy to Announce Unaudited Financial Results for the Second Quarter of 2026 on August 20, 2026

SHANGHAI, Aug. 6, 2026 /PRNewswire/ -- Daqo New Energy Corp. (NYSE: DQ) ("Daqo New Energy" or the "Company"), a leading manufacturer of high-purity polysilicon...

MediSun Energy and Guangdong Beijing Enterprises Shixi Technology Announce Global Distributorship for Advanced SBR-AGS Municipal Wastewater Solutions, Securing Exclusive Distribution in Malaysia and Saudi...

GUANGZHOU, China, Aug. 6, 2026 /PRNewswire/ -- MediSun Planet Pte Ltd ("MediSun Energy"), a leader in integrated water technology and advanced circular solutions, announced...